Brandon Temple/LinkedIn
Sep 18, 2026, 15:25
Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research
Brandon Temple, National Legislative Director at Critical Response Group, shared a post on LinkedIn:
“Life is full of surprises.
Never did I think I would be exercising my First Amendment right to petition our government advocating for research into warm autoimmune hemolytic anemia (wAIHA).
When my father in law was diagnosed with this rare blood disease the family felt helpless. I figured I could use my legislative expertise to do my part.
Mike is in compensated remission, but he too decided he needed to be a voice for those who are suffering with this rare disease.”
Stay updated with Hemostasis Today:
-
Sep 18, 2026, 15:01A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis
-
Sep 18, 2026, 14:52Abdul Muqtadir Abbasi: How Do Hematologists Know Which Coagulation Factor Is the Problem?
-
Sep 18, 2026, 14:48Kato Ramaekers: Redefining Integrin αIIbβ3 in Platelet Formation
-
Sep 18, 2026, 14:33Heghine Khachatryan: The discussion of Thrombophilia, APS and Coagulation Testing
-
Sep 18, 2026, 14:27Maria Cherska: Are We Overlooking the Spleen in Cardiometabolic Research?
-
Sep 18, 2026, 14:05Wolfram Ruf: Managing Thrombotic Risk in Pregnancy
-
Sep 18, 2026, 13:38Sam Tsimikas: Uncovering a Modifiable Lp(a) Phenotype in Hypertriglyceridemia
-
Sep 18, 2026, 13:22Christine Rabinak: Predictive Modeling for Individualized Unfractionated Heparin Dosing
-
Sep 18, 2026, 13:07Bastu Odoka: Principles of Pediatric Transfusion Dosing